Dr. Sabine Luttmann

Studies of human medicines, Freie Universität Berlin
1993-1995 Junior Doctor, Internal Medicine, Krankenhaus im Friedrichshain, Berlin
1995-2005 Research associate, Center of Epidemiology and Health Research, Berlin
2001 Degree of doctor in human medicine. Doctoral thesis: "About the validity of interview data regarding the use of oral contraceptives"
2006-2008 Medical scientist at Clinical Research Hamburg GmbH
since 2008 Research associate, Leibniz Institute for Prevention Research and Epidemiology - BIPS

    Selected BIPS-Publications

  • Articles with peer review

  • Matz M, Valkov M, Sekerija M, Luttmann S, Caldarella A, Coleman MP, Allemani C, The CONCORD Working Group. Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: An analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3). Cancer Communications. 2023;43(9):963-980.
    https://doi.org/10.1002/cac2.12457
  • Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, Meyer M, Nennecke A, Rathmann W, Stabenow R, Wilsdorf-Köhler H, Kollhorst B, Reinders T. Verknüpfung von Abrechnungsdaten gesetzlicher Krankenkassen mit Daten epidemiologischer Krebsregister: Länderspezifische Möglichkeiten und Limitationen. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2022;65(5):615-623.
    https://doi.org/10.1007/s00103-021-03475-x
  • Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from population-based cancer registration for secondary data analysis: Methodological challenges and perspectives. Das Gesundheitswesen. 2020;82(Suppl. 1):S62-S71.
    https://doi.org/10.1055/a-1009-6466
  • Luttmann S, Eberle A, Kibele E, Ahrens W. Perspektiven für ein bundesweites Mortalitätsregister: Erfahrungen mit dem Bremer Mortalitätsindex. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2019;62(12):1500-1509.
    https://doi.org/10.1007/s00103-019-03049-y
    https://repository.publisso.de/resource/frl%3A6418415
  • Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K, GEKID Cancer Survival Working Group. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. International Journal of Cancer. 2017;141(11):2270-2280.
    https://doi.org/10.1002/ijc.30930
  • Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. European Journal of Cancer. 2017;84:81-87.
    https://doi.org/10.1016/j.ejca.2017.07.014
  • Makarova N, Brand T, Brünings-Kuppe C, Pohlabeln H, Luttmann S. A comparative analysis of premature mortality among urban immigrants in Bremen, Germany: A retrospective register-based linkage study. BMJ Open. 2016;6(3):e007875.
    https://doi.org/10.1136/bmjopen-2015-007875
  • Merz M, Jansen L, Castro FA, Hillengassa J, Salwender H, Weisel K, Scheide C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, for the GEKID Cancer Survival Workgroup and the DRST. Survival of elderly patients with multiple myeloma - Effect of upfront autologous stem cell transplantation. European Journal of Cancer. 2016;62:1-8.
    https://doi.org/10.1016/j.ejca.2016.04.004
  • Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. Journal of Hematology & Oncology. 2016;9:28.
    https://doi.org/10.1186/s13045-016-0257-2
  • Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, for the GEKID Cancer Survival Workgroup. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. International Journal of Cancer. 2016;139(6):1289-1296.
    https://doi.org/10.1002/ijc.30186
  • Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and the United States. Journal of Gastroenterology and Hepatology. 2015;30(10):1485-1491.
    https://doi.org/10.1111/jgh.12989
  • Eberle A, Jansen L, Castro FA, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, GEKID Survival Working Group. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung Cancer. 2015;90(3):528-533.
    https://doi.org/10.1016/j.lungcan.2015.10.007
  • Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M, im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Inzidenzzunahme des papillären Schilddrüsenkarzinoms in Deutschland. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2014;57(1):84-92.
    https://doi.org/10.1007/s00103-013-1884-1
  • Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H, GEKID Cancer Survival Working Group. Survival of ovarian cancer patients in Germany in the early 21st century: A period analysis by age, histology, laterality, and stage. European Journal of Cancer Prevention. 2013;22(1):59-67.
    https://doi.org/10.1097/CEJ.0b013e3283552e28
  • Gondos A, Hiripi E, Holleczek B, Luttmann S, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival among adolescents and young adults with cancer in Germany and the United States: An international comparison. International Journal of Cancer. 2013;133(9):2207-2215.
    https://doi.org/10.1002/ijc.28231
  • Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Luttmann S, Waldmann A, Brenner H, GEKID Cancer Survival Working Group. Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage. Acta Oncologica. 2012;51(7):915-921.
    https://doi.org/10.3109/0284186X.2012.708105
  • Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A, GEKID Cancer Survival Working Group. Up-to-date results on survival of patients with melanoma in Germany. British Journal of Dermatology. 2012;167(3):606-612.
    https://doi.org/10.1111/j.1365-2133.2012.11039.x
  • Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H, GEKID Cancer Survival Working Group. Survival from common and rare cancers in Germany in the early 21st century. Annals of Oncology. 2012;23(2):472-479.
    https://doi.org/10.1093/annonc/mdr131
  • Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H, GEKID Cancer Survival Working Group. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncologica. 2012;51(7):906-914.
    https://doi.org/10.3109/0284186X.2012.673732
  • Eberle A, Luttmann S, Foraita R, Pohlabeln H. Socioeconomic inequalities in cancer incidence and mortality - spatial analysis in Bremen/Germany. Journal of Public Health. 2010;18(3):227-235.
    https://doi.org/10.1007/s10389-009-0306-1
  • Letters

  • Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K, GEKID Cancer Survival Working Group. Response: Methods for second primary cancers evaluation have to be standardized. International Journal of Cancer. 2018;142(6):1286-1287. (Response to International Journal of Cancer 2018;142(6):1285).
    https://doi.org/10.1002/ijc.31151
  • Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century. Haematologica. 2017;102(6):e229-e232.
    https://doi.org/10.3324/haematol.2016.157768
  • Behrens T, Lehmann C, Luttmann S. National mortality register. Deutsches Ärzteblatt International. 2011;108(6):96. (Response to Deutsches Ärzteblatt International 2010;107(33):575-588).
    https://doi.org/10.3238/arztebl.2011.0096b
  • Articles without peer review

  • Jansen L, Moratin J, Behr C, Holleczek B, Luttmann S, Peters F, Robers G, Schmidt-Porkzywniak A, Pritzkuleit R, Sirri E, Stang A, Arndt V. Epidemiologie von Kopf-Hals-Tumoren in Deutschland. Die Onkologie. 2023;29(1):5-11.
    https://doi.org/10.1007/s00761-022-01265-x
  • Luttmann S, Eberle A, Hübner J. Epidemiologie der Adenokarzinome des Ösophagus und des ösophagogastralen Übergangs. Die Onkologie. 2023;29(6):470-478.
    https://doi.org/10.1007/s00761-023-01350-9
  • Books

  • Bowles D, Götz M, Kehrbach A, Nerlich-Bronowicki C, Post A, Uecker S-M, Wessolowski-Müller, Gesa, Becker W, Jung F, Kellner C, Mohammadzadeh Z, Sawallisch F, Tempel G, Janke E, Meißner U, Dreger S, Grill S, Kollhorst B, Luttmann S, Pohlabeln H, Zeeb H. Landesgesundheitsbericht Bremen 2019. Bremen: Eigenverlag; 2019.
    https://www.gesundheit.bremen.de/gesundheit/berichte_zur_gesundheit-4571.
  • Book chapters

  • Luttmann S, Holzmann M. Unbekannte und unspezifische Primärtumoren. In: Stegmaier C, Hentschel S, Hofstädter F, Katalinic A, Tillack A, Klinkhammer-Schalke M, editors. Das Manual der Krebsregistrierung. 2. Auflage. München: Zuckschwerdt. 2018. S. 45-45.
  • Posters at scientific meetings/conferences

  • Luttmann S, Lehmann C, Eberle A. Adenokarzinome des Ösophagus, Magens und ösophagogastralen Übergangs. 13. Bremer Krebskongress, 5.-6. November 2013, Bremen.

For further publications please follow this link:

The responsibility for the content of this page lies with Sabine Luttmann.

Contact

Phone:
+49 (0)421 218-56-961